أن المبلغين لقانون الممارسات الاجنبية الفاسدة  و الذين بلغوا عن شركات الرعاية الصحية وشركات الادوية التي تقوم برشوة الأطباء والمسؤولين الحكوميين قد يكونون مؤهلين للحصول على مكافأة في إطار برنامج مكافأة يسمى برنامج دود فرانك . وعادة يكون الفساد في قطاع شركات الادوية و...

As recompensas da Dodd-Frank estão disponíveis para indivíduos que denunciem violações corporativas da Lei Sobre a Prática de Corrupção no Exterior (Foreign Corrupt Practices Act - FCPA). Na verdade, os denunciantes da FCPA podem se dar muito bem com o programa de...

Информаторы, предосталяющие сведения о подкупе медицинскими компаниями врачей или госчиновников, могут получить хорошее вознаграждение в рамках программы Додда-Франка (Dodd-Frank reward program). Этот пост - первая часть в серии, где будет рассмотрена международная...

When it comes to making a reward submission under the Dodd-Frank program, SEC whistleblowers should not let perfect evidence be the enemy of the good. International whistleblowers are eligible for large rewards for reporting corporate bribery under the Dodd-Frank...

Анонимные осведомители, сообщающие об откатах и взятках в IT и Telecom компаниях, для продаж подкупающих госчиновников, могут получить денежное вознаграждение в рамках поощрительной программы Додда-Франка. Этот пост - первая часть в серии, где будет рассмотрена...

Bribery rewards are available to international managers. Local country senior managers working for qualifying companies are eligible for large rewards for reporting bribery confidentially to the U.S. Securities and Exchange Commission (SEC). The Dodd-Frank reward...

针对制药公司贿赂医生和政府官员的FCPA举报人有可能获得多德 - 弗兰克计划的奖励。 这是一个系列文章的第一部分，将探讨国际制药腐败和如何发现/确定潜在的奖励信息。 为了更好地理解制药行业的腐败行为，我们应该关注从制药到关键意见领袖和医生的钱流，这些钱都是由制药公司直接支付或间接通过第三方来支付，以便让他们的产品进入医处方上，并获得更多购买。 第二部分考察了制药贿赂监管官员， 第三部分考察了制药贿赂医生雇用他们及其亲属。...

Section 922 of the Dodd-Frank Act makes it illegal for employers to retaliate against whistleblowers who report securities violations to the SEC under the reward program. The SEC has the authority to pursue a whistleblower retaliation case and punish companies for...

FCPA whistleblowers who report technology, telecom, and communications (collectively tech) companies bribing government officials may be eligible for a reward under the Dodd-Frank reward program. This is part one in a series that will examine international tech...

Pharma FCPA whistleblowers who report healthcare companies bribing government doctors or officials may be eligible for a reward under the Dodd-Frank program. Some of the ways pharma bribes government doctors and regulatory officials are by engaging them as...